Ftse Mib
34.504,62
-0,45%
DAX
0,00
0,00%
S&P 500
5.357,87
0,20%
NASDAQ
17.130,10
-0,02%
Bitcoin
69.882,16
0,33%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Renalytix PLC (RNLX) Renalytix PLC (RNLX) Notizie

RNLX

Renalytix (RNLX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RNLX
DataOraFonteTitoloSimboloCompagnia
05/06/202422:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RNLXRenalytix PLC
28/05/202413:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
15/05/202416:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RNLXRenalytix PLC
15/05/202413:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RNLXRenalytix PLC
15/05/202413:00GlobeNewswire Inc.Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024NASDAQ:RNLXRenalytix PLC
09/05/202413:00GlobeNewswire Inc.Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15NASDAQ:RNLXRenalytix PLC
08/04/202413:00GlobeNewswire Inc.Renalytix Announces Financing with Expected Size of up to $4 MillionNASDAQ:RNLXRenalytix PLC
14/03/202412:00GlobeNewswire Inc.KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)NASDAQ:RNLXRenalytix PLC
15/02/202413:00GlobeNewswire Inc.Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024NASDAQ:RNLXRenalytix PLC
09/02/202415:00GlobeNewswire Inc.Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASDAQ:RNLXRenalytix PLC
10/01/202413:00GlobeNewswire Inc.New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney diseaseNASDAQ:RNLXRenalytix PLC
17/11/202322:01Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:RNLXRenalytix PLC
14/11/202313:00GlobeNewswire Inc.Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024NASDAQ:RNLXRenalytix PLC
07/11/202313:00GlobeNewswire Inc.Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14NASDAQ:RNLXRenalytix PLC
03/11/202321:04Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:RNLXRenalytix PLC
06/10/202313:00GlobeNewswire Inc.US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to RenalytixNASDAQ:RNLXRenalytix PLC
28/09/202313:00GlobeNewswire Inc.Renalytix Reports Full Year Fiscal 2023 ResultsNASDAQ:RNLXRenalytix PLC
25/09/202313:00GlobeNewswire Inc.Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28NASDAQ:RNLXRenalytix PLC
07/09/202313:00GlobeNewswire Inc.Renalytix Appoints Senior Executive Howard Doran as Chief Business OfficerNASDAQ:RNLXRenalytix PLC
03/08/202313:00GlobeNewswire Inc.Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkdNASDAQ:RNLXRenalytix PLC
21/07/202313:00GlobeNewswire Inc.Renalytix Announces Middle East Distribution Agreement with Vector PharmaNASDAQ:RNLXRenalytix PLC
07/07/202313:00GlobeNewswire Inc.Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific SessionsNASDAQ:RNLXRenalytix PLC
03/07/202313:00GlobeNewswire Inc.Renalytix Appoints Financial Executive Catherine Coste to its Board of DirectorsNASDAQ:RNLXRenalytix PLC
30/06/202313:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RNLXRenalytix PLC
30/06/202300:58Dow Jones NewsRenalytix Gets FDA De Novo Marketing Authorization for KidneyIntelX.dkdNASDAQ:RNLXRenalytix PLC
30/06/202300:01GlobeNewswire Inc.FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney DiseaseNASDAQ:RNLXRenalytix PLC
15/06/202313:00GlobeNewswire Inc.KidneyIntelX™ Clinical Decision Impact / Validation and Health Economic Data to be Presented at Upcoming Scientific ConferencesNASDAQ:RNLXRenalytix PLC
09/06/202313:00GlobeNewswire Inc.Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023NASDAQ:RNLXRenalytix PLC
05/06/202313:00GlobeNewswire Inc.Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9NASDAQ:RNLXRenalytix PLC
25/05/202313:00GlobeNewswire Inc.Renalytix selects EVERSANA® to expand commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 DiabetesNASDAQ:RNLXRenalytix PLC
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RNLX

La tua Cronologia

USOTC
JMPLF
Johnson Matthey Public (PK)
EU
ETDD
Bnp Paribas Easy Euro St...
LSE
AP42
Cred Ag Co 29
EU
ETAPD
France Emprunt dEetat 0....
BIT
P1ND36
BNP Paribas Issuance
BIT
F38933
Vontobel Financial Produ...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network